Invasive pneumococcal disease

Pneumococcal diseases are symptomatic infections caused by the bacterium Streptococcus pneumoniae (S. pneumoniae), commonly referred to as pneumococci. The term invasive pneumococcal disease (IPD) is used for more severe and invasive pneumococcal infections, such as bacteraemia, sepsis, meningitis and osteomyelitis, in which the bacterium can be isolated from normally sterile sites. Pneumococcal infections and IPDs are major causes of communicable disease morbidity and mortality in Europe and globally, with the highest burden of disease found in young children and the elderly. A large proportion of IPD is vaccine preventable.

Read more

Latest outputs

Publication

External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019

External quality assessment -

Peer-Reviewed Publication

Automated digital reporting of clinical laboratory information to national public health surveillance systems, results of a EU/EEA survey, 2018

Oct 2020

Publication

Invasive pneumococcal disease - Annual Epidemiological Report for 2018

Surveillance report -

Peer-Reviewed Publication

A cluster of Legionnaires' disease in Belgium linked to a cooling tower, August-September 2016: Practical approach and challenges

Dec 2019

Publication

Invasive pneumococcal disease - Annual Epidemiological Report for 2017

Surveillance report -

Related content

Vaccine-preventable diseases

2009 influenza A (H1N1) pandemic

Disease / public health area

Cholera

Disease / public health area

Congenital rubella syndrome (CRS)

Disease / public health area

COVID-19

Disease / public health area

Diphtheria

Disease networks

European Invasive Bacterial Disease Surveillance Network (EU-IBD)

EUVAC.Net

EU/EEA National Immunisation Technical Advisory Groups (NITAG) collaboration